Cited 0 time in
CRISPR/Cas9 system as an innovative genetic engineering tool: Enhancements in sequence specificity and delivery methods
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Jo, Young-Il | - |
| dc.contributor.author | Suresh, Bharathi | - |
| dc.contributor.author | Kim, Hyongbum | - |
| dc.contributor.author | Ramakrishna, Suresh | - |
| dc.date.accessioned | 2022-07-15T19:57:55Z | - |
| dc.date.available | 2022-07-15T19:57:55Z | - |
| dc.date.issued | 2015-12 | - |
| dc.identifier.issn | 0304-419X | - |
| dc.identifier.issn | 1879-2561 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/155701 | - |
| dc.description.abstract | While human gene therapy has gained significant attention for its therapeutic promise, CRISPR/Cas9 technology has made a breakthrough as an efficient genome editing tool by emulating prokaryotic immune defense mechanisms. Although many studies have found that CRISPR/Cas9 technology is more efficient, specific and manipulable than previous generations of gene editing tools, it can be further improved by elevating its overall efficiency in a higher frequency of genome modifications and reducing its off-target effects. Here, we review the development of CRISPR/Cas9 technology, focusing on enhancement of its sequence specificity, reduction of off-target effects and delivery systems. Moreover, we describe recent successful applications of CRISPR/Cas9 technology in laboratory and clinical studies. | - |
| dc.format.extent | 10 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Elsevier BV | - |
| dc.title | CRISPR/Cas9 system as an innovative genetic engineering tool: Enhancements in sequence specificity and delivery methods | - |
| dc.type | Article | - |
| dc.publisher.location | 네델란드 | - |
| dc.identifier.doi | 10.1016/j.bbcan.2015.09.003 | - |
| dc.identifier.scopusid | 2-s2.0-84946430785 | - |
| dc.identifier.wosid | 000366226000006 | - |
| dc.identifier.bibliographicCitation | Biochimica et Biophysica Acta - Reviews on Cancer, v.1856, no.2, pp 234 - 243 | - |
| dc.citation.title | Biochimica et Biophysica Acta - Reviews on Cancer | - |
| dc.citation.volume | 1856 | - |
| dc.citation.number | 2 | - |
| dc.citation.startPage | 234 | - |
| dc.citation.endPage | 243 | - |
| dc.type.docType | Review | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | sci | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
| dc.relation.journalResearchArea | Biophysics | - |
| dc.relation.journalResearchArea | Oncology | - |
| dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
| dc.relation.journalWebOfScienceCategory | Biophysics | - |
| dc.relation.journalWebOfScienceCategory | Oncology | - |
| dc.subject.keywordPlus | RNA-GUIDED ENDONUCLEASE | - |
| dc.subject.keywordPlus | PLURIPOTENT STEM-CELLS | - |
| dc.subject.keywordPlus | TAL EFFECTOR NUCLEASES | - |
| dc.subject.keywordPlus | CAS SYSTEMS | - |
| dc.subject.keywordPlus | HOMOLOGOUS RECOMBINATION | - |
| dc.subject.keywordPlus | SACCHAROMYCES-CEREVISIAE | - |
| dc.subject.keywordPlus | FUNCTIONAL GENOMICS | - |
| dc.subject.keywordPlus | SEED SEQUENCE | - |
| dc.subject.keywordPlus | IMMUNE-SYSTEM | - |
| dc.subject.keywordPlus | GENERATION | - |
| dc.subject.keywordAuthor | Delivery methods | - |
| dc.subject.keywordAuthor | Genome editing | - |
| dc.subject.keywordAuthor | Reduced off-target effects | - |
| dc.subject.keywordAuthor | Sequence specificity | - |
| dc.subject.keywordAuthor | Therapeutics | - |
| dc.subject.keywordAuthor | CRISPR/Cas9 applications | - |
| dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0304419X15000700?via%3Dihub | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
